A Randomized, Open-label Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of the Combination of YN001 and Oral Rosuvastatin Calcium Tablets in Healthy Chinese Individuals
Latest Information Update: 05 Jan 2026
At a glance
- Drugs YN 001 (Primary) ; Rosuvastatin
- Indications Atherosclerosis
- Focus Adverse reactions
- Sponsors Beijing Inno Medicine
Most Recent Events
- 05 Jan 2026 New trial record